Related Staff
Herbert Opi | Rhea Longley | Linda Reiling | Leanne Robinson | Ivo Mueller | James Beeson
Published: February 26, 2026
D. Herbert Opi, Rhea J. Longley, Eizo Takashima, Tim Spelman, Yanie Tayipto, Kael Schoffer, Jessica Brewster, Linda Reiling, Bruce D. Wines, Benson Kiniboro, Peter Siba, Matthias Harbers, Mark Hogarth, Takafumi Tsuboi, Leanne J. Robinson, Ivo Mueller, James G. Beeson. A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria, Immunity,2026,,ISSN 1074-7613, https://doi.org/10.1016/j.immuni.2026.02.003.
Plasmodium vivax is the most widespread cause of malaria with a high burden of disease. Progress in reducing the global malaria burden has stalled with no vaccines available partly due to a limited knowledge of targets and mechanisms of protective immunity. We developed a platform to quantify antibody functions to multiple P. vivax antigens and dissect immunity in a longitudinal cohort of children from Papua New Guinea at risk of P. vivax malaria. We identified antigens targeted by multiple functional antibodies, including interactions with Fcγ receptors, which mediate different cellular effector functions, and complement fixation, advancing our understanding of P. vivax immunity. We identified specific antigens targeted by antibodies associated with protection from P. vivax malaria. Evaluating thousands of possible combinations, we identified subsets of antigens in the most protective combinations providing leads for developing highly protective multi-antigen P. vivax vaccines eliciting multi-functional antibody responses to achieve and sustain elimination.
Herbert Opi | Rhea Longley | Linda Reiling | Leanne Robinson | Ivo Mueller | James Beeson